Biotech: Page 50
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Business not as usual. This month’s Forum — Virtual Pharma: Cheaper, Faster, but Doable? — hits a chord particularly close to home to us at PharmaVOICE. Over the past eight years, we’ve witnessed more than just a few companies coming to a virtual reality. In fact, Stan Bernard of Bernard and Asso...
By Taren Grom • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
Doctors' Choice Awards
Identifying POWERful MEDICAL ADVERTISING 6th Annual Program Generated Responses From More Than 5,700 Physicians Dusa’s ClindaReach and Pfizer’s Chantix Highest Scoring Ads ClindaReach Category: Highest-Scoring Ad (Specialist Audience) Marketer: Dusa Agency: Topin & Associates Chantix Category...
By PharmaVoice Team • Nov. 22, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
The Corner Office
Corporate Strategy A review of the annual reports and public statements of more than two dozen of the industry’s publicly traded pharmaceutical/biotechnology companies reveals the top trends as identified by the CEOs, presidents, and executive management teams of these industry standard bearers. ...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
At A Glance
Looking Forward At a GLANCE This special Year in Preview issue provides insights into the trends that will impact the industry in the coming year and beyond. Below are some highlights from the sectors covered in the following pages. Focus on specialty markets David Avitabile President JFK Communi...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
An Industry Overview
The industry started feeling the pinch of belt-tightening almost a decade ago, slowly at first. But today’s pressures must feel like a vise grip. Being squeezed from all sides, life-sciences companies are having to counter multiple challenges of tremendous magnitude: increased regulatory scrutiny...
By Robin Robinson And Denise Myshko • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Barry Goldstein Merck Appoints Head of Diabetes, Obesity Development Global pharmaceutical company Merck, Whitehouse Station, N.J., has named Barry Goldstein, M.D., Ph.D., FACP, FACE, VP of diabetes and obesity clinical development. In addition to leading overall development of co...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES The latest interactive sales training guide from Total Learning Concepts, Introduction to Pharmaceutical Sales, uses the company’s serious gaming technology platform, Qube, to provide a comprehensive primer for under standing and ...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTHCARE RELATED PRODUCTS, SERVICES, AND COMPANIES The American Heart Association has launched the last of its updated cardiology subspecialty journals published under the banner of Circulation: Journal of the American Heart Association by Lippincott Williams &Wilkins, part of Wolters K...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
CONSUMER PERSPECTIVE Consumers Wary of Therapeutic Switches Almost three quarters of prescription drug users would be very concerned if a drug they were prescribed was switched to another drug designed to treat the same condition without their doctor’s knowledge, according to a survey released by...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Contents November/December 2008 98 PATIENT EDUCATION Product managers still need to reach patients with messages that resonate on a personal level. 102 DOCTORS’CHOICE AWARDS A review of the 2008 winners. IN EVERY ISSUE 3 Letter from the Editor 6 UpFront 104 What’s New 108 EMedia 113 OnThe Calenda...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Pharmaceutical companies as well as their partners are feeling the heat. They are facing unprecedented challenges on a global scale. More so than ever, their business strategies are being put to the test. How well they do will depend on the resilience of their operations and the vision of their l...
By Taren Grom • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Medicare Incentives Push E-Prescribing to Top of Mind
2008 VIEW on ESolutions EPRESCRIBING It’s no secret that thousands of private practice physicians throughout the country face a financial crunch. Declining reimbursement rates have produced a profoundly negative impact in several areas of healthcare — particularly in oncology, nephrology and othe...
By PharmaVoice Team • Oct. 24, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Leonard Bell, M.D.,CEO of Alexion, is also the Principal Founder of the biopharmaceutical company, which was established in 1992.From 1991 to 1992, Dr.Bell was Codirector of the Program in Vascular Biology at the Yale University School of Medicine,where starting in 1990 he had also been an Assist...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Mark GLICKMAN Oscient Promotes Sales Executive Commercial stage pharmaceutical company Oscient Pharmaceuticals, Waltham, Mass., has promoted Mark Glickman to senior VP, sales and marketing, and corporate officer. Since joining Oscient in August 2007 as VP of sales, Mr. Glickman has be...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
October 15 3rd Leadership Summit on Medicare Enrollment and PDE Data Reconciliation Hilton Old Town, Alexandria, Va. PharmaVOICE subscribers receive $300 discount; register using keycode HYU957. For more information, contact Jodi Bova, Center for Business Intelligence, at 781-939-2563, email jodi...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
The Green Movement: Rethinking Chemistry
BY DENISE MYSHKO Major pharmaceutical companies are working together to minimize the environmental impact of how they make their products. The GREEN MOVEMENT Rethinking Chemistry GREEN IS THE NEW BLACK. The push to make prescription drugs more efficient, cleaner, and safer is gaining momentum ami...
By Denise Myshko • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
A New Era of Drug Safety
BY DENISE MYSHKO NEW REGULATIONS IN THE UNITED STATES AND EUROPE HAVE TRIGGERED A NEED FOR BETTER TOOLS FOR THE COLLECTING, REPORTING,AND ANALYSIS OF PATIENT SAFETY DATA. As regulators around the globe demand more data on each drug’s profile, the need for technologies to support drug safety has b...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Jason Cohen joined GE Healthcare Financial Services in 2006 and is a Senior VP and Pharmaceuticals Analyst. In this role, he helps lead the GE corporate finance efforts within specialty pharma, generics, biotechnology, and outsourced services. Additionally, he provides guidance and oversight on v...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
4th Integrating Electronic Health Records and eClinical Technologies Conference Baltimore Marriott Waterfront Hotel,Baltimore For more information, contact Jasmaine John, ExL Pharma,at 2124006235, email [email protected], or visit exlpharma.com. September 1516 Biotech Patents Royal Sonesta Hote...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Safe-BioPharma Activates Electronic Identity Link Octagon Research Provides System for Submissions Targetbase Introduces Customized Direct-to-Patient Solutions Visual i|o Launches Portfolio Management System E-Upg...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
The Rules Change Again
August 2008 VIEW on Medical Education THE FORUM News of Pfizer’s decision to eliminate all direct funding for physician CME programs provided by medical education and communication companies (MECCs) — the first such move by a major pharmaceutical company — has rattled even this most dynamic of se...
By PharmaVoice Team • Aug. 20, 2008 -
PharmaVoice Team/PharmaVoice
Cover
PharmaVOICE PharmaVOICE 100 THE FORUM FOR THE INDUSTRY EXECUTIVE July/August 2008 SPECIAL ISSUE 100 of the Most Inspiring People www.pharmavoice.com Download PDF
By PharmaVoice Team • July 28, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PharmaVOICE is delighted to publish the fourth annual special issue featuring 100 of the most inspiring individuals in the life-sciences industry. This issue has become one of my favorites and, from all accounts, one of yours as well. What’s not to love? This issue celebrates the men and women of...
By Taren Grom • July 27, 2008 -
PharmaVoice Team/PharmaVoice
The Mentors
Brian Corvino Mary Lacquaniti Lelia O’Connor Danita Sutton, Ph.D. MENTORING AND SHAPING THE CAREERS OF OTHERS ARE VENERABLE AND ADMIRABLE TALENTS. MENTORING TAKES PATIENCE, FORESIGHT, AND UNSELFISH DEVOTIONTO OTHERS’ SUCCESS and is a skill that is often unheralded — until now. We salute those who...
By PharmaVoice Team • July 24, 2008 -
PharmaVoice Team/PharmaVoice
The Technologists
Valdo Arnera, M.D. Bill Byrom, Ph.D. Philip A. Garland Keith Howells Don Schenker Rodney Spady A creative and passionate approach to pioneering new areas of technology applications and new products has enabled Dr. Bill Byrom to engender real improvements in the drug development process. For the p...
By PharmaVoice Team • July 24, 2008
Previous
